BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 26486855)

  • 1. Long-Term Suppression of Atrial Fibrillation by Botulinum Toxin Injection Into Epicardial Fat Pads in Patients Undergoing Cardiac Surgery: One-Year Follow-Up of a Randomized Pilot Study.
    Pokushalov E; Kozlov B; Romanov A; Strelnikov A; Bayramova S; Sergeevichev D; Bogachev-Prokophiev A; Zheleznev S; Shipulin V; Lomivorotov VV; Karaskov A; Po SS; Steinberg JS
    Circ Arrhythm Electrophysiol; 2015 Dec; 8(6):1334-41. PubMed ID: 26486855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term suppression of atrial fibrillation by botulinum toxin injection into epicardial fat pads in patients undergoing cardiac surgery: Three-year follow-up of a randomized study.
    Romanov A; Pokushalov E; Ponomarev D; Bayramova S; Shabanov V; Losik D; Stenin I; Elesin D; Mikheenko I; Strelnikov A; Sergeevichev D; Kozlov B; Po SS; Steinberg JS
    Heart Rhythm; 2019 Feb; 16(2):172-177. PubMed ID: 30414841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Botulinum Toxin Type A for the Prevention of Postoperative Atrial Fibrillation.
    Piccini JP; Ahlsson A; Dorian P; Gillinov AM; Kowey PR; Mack MJ; Milano CA; Noiseux N; Perrault LP; Ryan W; Steinberg JS; Voisine P; Waldron NH; Gleason KJ; Titanji W; Leaback RD; O'Sullivan A; Ferguson WG; Benussi S;
    JACC Clin Electrophysiol; 2024 May; 10(5):930-940. PubMed ID: 38661602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carperitide and atrial fibrillation after coronary bypass grafting: the Nihon University working group study of low-dose HANP infusion therapy during cardiac surgery trial for postoperative atrial fibrillation.
    Sezai A; Iida M; Yoshitake I; Wakui S; Osaka S; Kimura H; Yaoita H; Hata H; Shiono M; Nakai T; Takayama T; Kunimoto S; Kasamaki Y; Hirayama A
    Circ Arrhythm Electrophysiol; 2015 Jun; 8(3):546-53. PubMed ID: 25840580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin injection in epicardial autonomic ganglia temporarily suppresses vagally mediated atrial fibrillation.
    Oh S; Choi EK; Zhang Y; Mazgalev TN
    Circ Arrhythm Electrophysiol; 2011 Aug; 4(4):560-5. PubMed ID: 21659633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy of epicardial application of drug-releasing hydrogels to prevent postoperative atrial fibrillation.
    Wang W; Mei YQ; Yuan XH; Feng XD
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):80-5. PubMed ID: 26254755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin injection in epicardial fat pads can prevent recurrences of atrial fibrillation after cardiac surgery: results of a randomized pilot study.
    Pokushalov E; Kozlov B; Romanov A; Strelnikov A; Bayramova S; Sergeevichev D; Bogachev-Prokophiev A; Zheleznev S; Shipulin V; Salakhutdinov N; Lomivorotov VV; Karaskov A; Po SS; Steinberg JS
    J Am Coll Cardiol; 2014 Aug; 64(6):628-9. PubMed ID: 25104535
    [No Abstract]   [Full Text] [Related]  

  • 8. Temporary autonomic modulation with botulinum toxin type A to reduce atrial fibrillation after cardiac surgery.
    Waldron NH; Cooter M; Haney JC; Schroder JN; Gaca JG; Lin SS; Sigurdsson MI; Fudim M; Podgoreanu MV; Stafford-Smith M; Milano CA; Piccini JP; Mathew JP
    Heart Rhythm; 2019 Feb; 16(2):178-184. PubMed ID: 30414840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial Fibrillation After Coronary Artery Bypass Surgery: Can Ivabradine Reduce Its Occurrence?
    Abdel-Salam Z; Nammas W
    J Cardiovasc Electrophysiol; 2016 Jun; 27(6):670-6. PubMed ID: 27006322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of results of surgical treatment for persistent atrial fibrillation during coronary artery bypass grafting using implantable loop recorders.
    Cherniavsky A; Kareva Y; Pak I; Rakhmonov S; Pokushalov E; Romanov A; Karaskov A
    Interact Cardiovasc Thorac Surg; 2014 Jun; 18(6):727-31. PubMed ID: 24572769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefit of ablation of first diagnosed paroxysmal atrial fibrillation during coronary artery bypass grafting: a pilot study.
    Pokushalov E; Romanov A; Corbucci G; Cherniavsky A; Karaskov A
    Eur J Cardiothorac Surg; 2012 Mar; 41(3):556-60. PubMed ID: 22219409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When should we discontinue antiarrhythmic therapy for atrial fibrillation after coronary artery bypass grafting? A prospective randomized study.
    Izhar U; Ad N; Rudis E; Milgalter E; Korach A; Viola N; Levi E; Asraff G; Merin G; Elami A
    J Thorac Cardiovasc Surg; 2005 Feb; 129(2):401-6. PubMed ID: 15678052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of an implantable monitor to detect arrhythmia recurrences and select patients for early repeat catheter ablation for atrial fibrillation: a pilot study.
    Pokushalov E; Romanov A; Corbucci G; Artyomenko S; Turov A; Shirokova N; Karaskov A
    Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):823-31. PubMed ID: 21930653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vernakalant hydrochloride for the rapid conversion of atrial fibrillation after cardiac surgery: a randomized, double-blind, placebo-controlled trial.
    Kowey PR; Dorian P; Mitchell LB; Pratt CM; Roy D; Schwartz PJ; Sadowski J; Sobczyk D; Bochenek A; Toft E;
    Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):652-9. PubMed ID: 19948506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of epicardial anterior fat pad retention on postcardiothoracic surgery atrial fibrillation incidence: the AFIST-III Study.
    White CM; Sander S; Coleman CI; Gallagher R; Takata H; Humphrey C; Henyan N; Gillespie EL; Kluger J
    J Am Coll Cardiol; 2007 Jan; 49(3):298-303. PubMed ID: 17239710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiofrequency catheter ablation and antiarrhythmic drug therapy: a prospective, randomized, 4-year follow-up trial: the APAF study.
    Pappone C; Vicedomini G; Augello G; Manguso F; Saviano M; Baldi M; Petretta A; Giannelli L; Calovic Z; Guluta V; Tavazzi L; Santinelli V
    Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):808-14. PubMed ID: 21946315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Giving IV and oral amiodarone perioperatively for the prevention of postoperative atrial fibrillation in patients undergoing coronary artery bypass surgery: the GAP study.
    Kerstein J; Soodan A; Qamar M; Majid M; Lichstein E; Hollander G; Shani J
    Chest; 2004 Sep; 126(3):716-24. PubMed ID: 15364747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II-antagonist in paroxysmal atrial fibrillation (ANTIPAF) trial.
    Goette A; Schön N; Kirchhof P; Breithardt G; Fetsch T; Häusler KG; Klein HU; Steinbeck G; Wegscheider K; Meinertz T
    Circ Arrhythm Electrophysiol; 2012 Feb; 5(1):43-51. PubMed ID: 22157519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of atrial fibrillation after a failed initial ablation procedure in patients with paroxysmal atrial fibrillation: a randomized comparison of drug therapy versus reablation.
    Pokushalov E; Romanov A; De Melis M; Artyomenko S; Baranova V; Losik D; Bairamova S; Karaskov A; Mittal S; Steinberg JS
    Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):754-60. PubMed ID: 23748210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-day loading dose of oral amiodarone for the prevention of new-onset atrial fibrillation after coronary artery bypass surgery.
    Maras D; Bosković SD; Popović Z; Nesković AN; Kovacević S; Otasević P; Marinković J; Vuk L; Borzanović M; Nastasić S; Jovanović T; Bojić M; Babić R; Popović AD
    Am Heart J; 2001 May; 141(5):E8. PubMed ID: 11320383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.